Bailard’s Medicines Co MDCO Stock Holding History

Bailard’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-21,800	Closed	-$1.85M	–	608
2019 Q4	$1.85M	Sell	21,800 -43,200	-66%	-$2.88M	0.1%	160
2019 Q3	$3.25M	Sell	65,000 -3,000	-4%	-$120K	0.2%	107
2019 Q2	$2.48M	Sell	68,000 -15,500	-19%	-$506K	0.15%	138
2019 Q1	$2.33M	Sell	83,500 -500	-0.6%	-$11.8K	0.14%	145
2018 Q4	$1.61M	Buy	84,000 +14,000	+20%	+$326K	0.11%	166
2018 Q3	$2.09M	Buy	70,000 +37,500	+115%	+$1.41M	0.12%	157
2018 Q2	$1.19M	Buy	+32,500	New	+$1.06M	0.07%	203

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Bailard's MDCO Position: Q1 2020 in Review

Bailard sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 21,800 shares — an estimated $1.85M sold.

Bailard first reported a position in MDCO in Q2 2018 and held it in 7 quarters. The position peaked at $3.25M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Bailard reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Bailard sold 21,800 Medicines Co shares in Q1 2020, an estimated $1.85M.
Bailard first reported a position in Medicines Co in Q2 2018 and held it in 7 quarters.
Bailard's Medicines Co position peaked at $3.25M in Q3 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Bailard's 13F filing for Q1 2020, filed 16 Apr 2020.